William B. Smith

4.6k total citations
161 papers, 2.8k citations indexed

About

William B. Smith is a scholar working on Organic Chemistry, Spectroscopy and Physical and Theoretical Chemistry. According to data from OpenAlex, William B. Smith has authored 161 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Organic Chemistry, 41 papers in Spectroscopy and 24 papers in Physical and Theoretical Chemistry. Recurrent topics in William B. Smith's work include Molecular spectroscopy and chirality (29 papers), Chemical Reaction Mechanisms (13 papers) and Analytical Chemistry and Chromatography (12 papers). William B. Smith is often cited by papers focused on Molecular spectroscopy and chirality (29 papers), Chemical Reaction Mechanisms (13 papers) and Analytical Chemistry and Chromatography (12 papers). William B. Smith collaborates with scholars based in United States, United Kingdom and Germany. William B. Smith's co-authors include Michael Barfield, Thomas Marbury, Ben A. Shoulders, William G. Kramer, Paula Black, D. Craig Brater, Dennis Vargo, Cesare Orlandi, Lisa C. Costello‐Boerrigter and Christopher A. Zimmer and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

William B. Smith

155 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William B. Smith United States	28	847	514	429	427	344	161	2.8k
Yoshihiko Saito Japan	26	559 0.7×	802 1.6×	224 0.5×	187 0.4×	286 0.8×	178	3.4k
John K. Saunders Canada	29	600 0.7×	510 1.0×	217 0.5×	384 0.9×	377 1.1×	123	3.1k
Joseph Miller United States	25	585 0.7×	226 0.4×	268 0.6×	106 0.2×	276 0.8×	154	2.5k
Sachiko Yamada Japan	36	957 1.1×	1.1k 2.1×	93 0.2×	170 0.4×	204 0.6×	225	4.8k
Björn Lindström Sweden	32	291 0.3×	505 1.0×	142 0.3×	329 0.8×	269 0.8×	149	3.5k
John Hines United States	37	694 0.8×	1.3k 2.6×	109 0.3×	136 0.3×	485 1.4×	113	5.1k
Dwight R. Robinson United States	29	279 0.3×	1.3k 2.6×	174 0.4×	255 0.6×	364 1.1×	69	4.6k
Élise Dumont France	26	467 0.6×	992 1.9×	139 0.3×	235 0.6×	166 0.5×	132	2.6k
R. Srinivas India	27	428 0.5×	736 1.4×	125 0.3×	866 2.0×	88 0.3×	162	2.8k
Shigeo Yamamura Japan	25	273 0.3×	204 0.4×	374 0.9×	222 0.5×	104 0.3×	97	2.0k

Countries citing papers authored by William B. Smith

Since Specialization

Citations

This map shows the geographic impact of William B. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William B. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William B. Smith more than expected).

Fields of papers citing papers by William B. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William B. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William B. Smith. The network helps show where William B. Smith may publish in the future.

Co-authorship network of co-authors of William B. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of William B. Smith. A scholar is included among the top collaborators of William B. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William B. Smith. William B. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salas, José A., Elizabeth Merrall, Erik Buntinx, et al.. (2024). Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial. Vaccine. 43(Pt 1). 126514–126514. 4 indexed citations

Nicolas, Olivier, et al.. (2024). A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers. Clinical and Translational Science. 17(2). 5 indexed citations

Huestis, Marilyn A., et al.. (2024). MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model‐informed analysis. CPT Pharmacometrics & Systems Pharmacology. 14(2). 376–388.

Pinto, Gabriele, et al.. (2024). Hydrogen tunneling with an atypically small KIE measured in the mediated decomposition of the Co(CH₃COOH)⁺ complex. Physical Chemistry Chemical Physics. 26(43). 27741–27750.

Smith, William B., Timothy M. Clough, Mark Kagan, et al.. (2024). A Growth Differentiation Factor 15 Receptor Agonist in Randomized Placebo-Controlled Trials in Healthy or Obese Persons. The Journal of Clinical Endocrinology & Metabolism. 110(3). 771–786. 9 indexed citations

Smith, William B., et al.. (2021). Efficacy of a Fixed-Dose Combination of Ibuprofen and Acetaminophen Compared With Individual Monocomponents in Adult Male Subjects With Endotoxin-Induced Fever: A Randomized Controlled Trial. Clinical Therapeutics. 43(7). 1213–1227. 7 indexed citations

Wang‐Jairaj, Jie, Oscar Della Pasqua, Vijayalakshmi Chandrasekaran, et al.. (2020). Effect of raxibacumab on immunogenicity of Anthrax Vaccine Adsorbed: a phase 4, open-label, parallel-group, randomised non-inferiority study. The Lancet Infectious Diseases. 20(8). 983–991. 14 indexed citations

Smith, William B., et al.. (2017). Hot Button Protocol and Operational Issues Between Sponsors and Sites in Clinical Pharmacology Studies: A Moderated Forum Session. Therapeutic Innovation & Regulatory Science. 51(3). 298–302. 1 indexed citations

Smith, William B., George Newman, Margarita Askelson, et al.. (2017). The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation. BMC Nephrology. 18(1). 273–273. 7 indexed citations

10.

Smith, William B., et al.. (2016). Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study. Clinical Autonomic Research. 26(4). 269–277. 33 indexed citations

11.

Frenck, Robert W., Anne Fiquet, Alejandra Gurtman, et al.. (2016). Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older. Vaccine. 34(30). 3454–3462. 21 indexed citations

12.

Adkison, Kimberly K., Stephen D. Gardner, Étienne Dumont, et al.. (2015). Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ‐56914845 (GSK2336805) in subjects with hepatic impairment. The Journal of Clinical Pharmacology. 55(9). 1042–1050. 2 indexed citations

13.

Hu, Xiao, Ali Seddighzadeh, Ying Zhu, et al.. (2014). Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta‐1a in subjects with normal or impaired renal function. The Journal of Clinical Pharmacology. 55(2). 179–188. 8 indexed citations

14.

Stein, Evan A., Scott Mellis, George D. Yancopoulos, et al.. (2012). Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol. Obstetrical & Gynecological Survey. 67(7). 413–414. 10 indexed citations

15.

Smith, William B., Thomas Marbury, Steven F. Komjathy, et al.. (2012). Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension. European Journal of Clinical Pharmacology. 68(10). 1385–1394. 9 indexed citations

16.

Nunes, Irene, James A. Bolognese, Deborah L. Miller, et al.. (2010). Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure. Journal of the American Society of Hypertension. 4(6). 311–318. 6 indexed citations

17.

Smith, William B., Suzanne K. Swan, Thomas Marbury, & Herbert R. Henney. (2009). Single‐Dose Pharmacokinetics of Sustained‐Release Fampridine (Fampridine‐SR) in Healthy Volunteers and Adults With Renal Impairment. The Journal of Clinical Pharmacology. 50(2). 151–159. 34 indexed citations

18.

Kramer, William G., et al.. (1996). Pharmacodynamics of Torsemide Administered as an Intravenous Injection and as a Continuous Infusion to Patients with Congestive Heart Failure. The Journal of Clinical Pharmacology. 36(3). 265–270. 39 indexed citations

19.

Vargo, Dennis, et al.. (1995). Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*. Clinical Pharmacology & Therapeutics. 57(6). 601–609. 206 indexed citations

20.

Dziezyc, Joan, Nicholas J. Millichamp, & William B. Smith. (1992). Comparison of applanation tonometers in dogs and horses. Journal of the American Veterinary Medical Association. 201(3). 430–433. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact